[Skip to Content]
[Skip to Content Landing]
Article
May 9, 1959

CLINICAL EXPERIENCE WITH A NEW ERYTHROMYCIN DERIVATIVE, ERYTHROMYCIN PROPIONATE: REPORT OF ONE HUNDRED FIVE CASES

Author Affiliations

Iowa City

From the Infectious Disease Division, Department of Internal Medicine, College of Medicine, State University of Iowa, and the University Hospitals. Dr. Soderstrom is a Staff Physician at the Veterans Administration Hospital.

JAMA. 1959;170(2):184-188. doi:10.1001/jama.1959.03010020042013
Abstract

The effects of orally administered erythromycin propionate have been observed in 105 patients. Most of them took it four times a day or every six hours in one or two capsules containing 0.25 Gm., and in a few cases this medication was continued as long as two months. The diseases treated were particularly those caused by Staphylococcus aureus, and the series included cases of pustular acne, furuncles, carbuncles, and pyodermas. Good results were obtained in 98 patients, 10 of whom had previously failed to respond to other forms of chemotherapy. Only eight patients had side-effects such as anorexia or vomiting, and diarrhea occurred in but one patient. This derivative, erythromycin propionate, has the advantage over the parent compound in that it produces higher concentrations in the blood after oral ingestion.

×